William D. Waddill - Net Worth and Insider Trading

William D. Waddill Net Worth

The estimated net worth of William D. Waddill is at least $1 Million dollars as of 2024-12-27. William D. Waddill is the Director of Arrowhead Pharmaceuticals Inc and owns about 40,378 shares of Arrowhead Pharmaceuticals Inc (ARWR) stock worth over $788,582. William D. Waddill is the Director of Protagonist Therapeutics Inc and owns about 12,000 shares of Protagonist Therapeutics Inc (PTGX) stock worth over $474,120. William D. Waddill is also the SENIOR VP & CFO of Calithera Biosciences Inc and owns about 469 shares of Calithera Biosciences Inc (CALA) stock worth over $0. Details can be seen in William D. Waddill's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that William D. Waddill has not made any transactions after 2024-12-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of William D. Waddill

To

William D. Waddill Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, William D. Waddill owns 5 companies in total, including Protagonist Therapeutics Inc (PTGX) , Arrowhead Pharmaceuticals Inc (ARWR) , and Calithera Biosciences Inc (CALA) among others .

Click here to see the complete history of William D. Waddill’s form 4 insider trades.

Insider Ownership Summary of William D. Waddill

Ticker Comapny Transaction Date Type of Owner
PTGX Protagonist Therapeutics Inc 2024-09-10 director
ARWR Arrowhead Pharmaceuticals Inc 2024-12-17 director
CALA Calithera Biosciences Inc 2016-09-29 SR. VP & CFO
LIMIT LIMIT 2013-07-23 SVP & Chief Financial Officer
LIMIT LIMIT 2021-08-12 director

William D. Waddill Latest Holdings Summary

William D. Waddill currently owns a total of 3 stocks. Among these stocks, William D. Waddill owns 40,378 shares of Arrowhead Pharmaceuticals Inc (ARWR) as of December 17, 2024, with a value of $788,582 and a weighting of 62.45%. William D. Waddill owns 12,000 shares of Protagonist Therapeutics Inc (PTGX) as of September 10, 2024, with a value of $474,120 and a weighting of 37.55%. William D. Waddill also owns 469 shares of Calithera Biosciences Inc (CALA) as of October 1, 2014, with a value of $0 and a weighting of 0%.

Latest Holdings of William D. Waddill

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ARWR Arrowhead Pharmaceuticals Inc 2024-12-17 40,378 19.53 788,582
PTGX Protagonist Therapeutics Inc 2024-09-10 12,000 39.51 474,120
CALA Calithera Biosciences Inc 2014-10-01 469 0.00 0

Holding Weightings of William D. Waddill


William D. Waddill Form 4 Trading Tracker

According to the SEC Form 4 filings, William D. Waddill has made a total of 7 transactions in Arrowhead Pharmaceuticals Inc (ARWR) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Arrowhead Pharmaceuticals Inc is the sale of 7,495 shares on December 17, 2024, which brought William D. Waddill around $164,665.

According to the SEC Form 4 filings, William D. Waddill has made a total of 4 transactions in Protagonist Therapeutics Inc (PTGX) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Protagonist Therapeutics Inc is the sale of 8,000 shares on September 10, 2024, which brought William D. Waddill around $360,000.

According to the SEC Form 4 filings, William D. Waddill has made a total of 0 transactions in Calithera Biosciences Inc (CALA) over the past 5 years. The most-recent trade in Calithera Biosciences Inc is the sale of 0 shares on October 1, 2014, which brought William D. Waddill around $0.

Insider Trading History of William D. Waddill

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

William D. Waddill Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

William D. Waddill Ownership Network

Ownership Network List of William D. Waddill

No Data

Ownership Network Relation of William D. Waddill

Insider Network Chart

William D. Waddill Owned Company Details

What does Protagonist Therapeutics Inc do?

Who are the key executives at Protagonist Therapeutics Inc?

William D. Waddill is the director of Protagonist Therapeutics Inc. Other key executives at Protagonist Therapeutics Inc include Chief Medical Officer Arturo Md Molina , Chief Development Officer Suneel Gupta , and director & President and CEO Patel Dinesh V Ph D .

Protagonist Therapeutics Inc (PTGX) Insider Trades Summary

Over the past 18 months, William D. Waddill made 4 insider transaction in Protagonist Therapeutics Inc (PTGX) with a net sale of 36,975. Other recent insider transactions involving Protagonist Therapeutics Inc (PTGX) include a net sale of 265,000 shares made by Patel Dinesh V Ph D , a net sale of 39,624 shares made by Asif Ali , and a net sale of 35,283 shares made by Arturo Md Molina .

In summary, during the past 3 months, insiders sold 256,063 shares of Protagonist Therapeutics Inc (PTGX) in total and bought 0 shares, with a net sale of 256,063 shares. During the past 18 months, 504,510 shares of Protagonist Therapeutics Inc (PTGX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 504,510 shares.

Protagonist Therapeutics Inc (PTGX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Protagonist Therapeutics Inc Insider Transactions

No Available Data

William D. Waddill Mailing Address

Above is the net worth, insider trading, and ownership report for William D. Waddill. You might contact William D. Waddill via mailing address: C/o Calithera Biosciences, 343 Oyster Point Blvd, Suite 200, So. San Francisco Ca 94080.

Discussions on William D. Waddill

No discussions yet.